blog

F1000Prime Publisher Kathleen Wets visited Boston for the Experimental Biology (EB 2013) conference last month. Despite the city being in lock-down that day owing to the dramatic events unfolding just a stone’s throw away from his office, she met with Rudolf Jaenisch, Professor of Biology at MIT and a Head of Faculty for Genomics & Genetics at F1000Prime.

Here, Professor Jaenisch, one of the pioneers of transgenic science and therapeutic cloning, tells us about his current research into stem cells. Specifically, the reprogramming of somatic cells to a pluripotent state and what this technology could mean for the study of complex diseases like Parkinson’s and Alzheimer’s, and for the sufferers of these conditions.